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Summary
Transplantation has strong deleterious effects on the primitive immunohematopoietic stem cells
(PSC) from which circulating lymphocytes and erythrocytes are descended. We studied these
effects over 300-400 d, testing whether PSC numbers, repopulating abilities, or both, were reduced.
Equivalent PSC numbers were estimated in recipients of mixtures of genetically different cells,
usingthe binomial model with covariance. Percentages of lymphocyte and erythrocyte types were
closely correlated, as were percentages of either type sampled at intervals of several months. This
suggests that the same PSC produced lymphoid and myeloid cells, and that most circulating
cells were descended from the same PSC over hundreds of days. Equivalent PSC concentrations
were "1/105 fresh marrow cells, and were about twofold lower using previously transplanted
marrow. However, such marrow repopulated only one-seventh to one-eighth as well as fresh
marrow. Apparently, transplantation not only reduces PSC concentrations, but also reduces the
repopulating ability per PSC. This may result from excessive stimuli to differentiate that overbalance
the stimuli for PSC to replenish themselves.
T
he most primitive stem cell (PSC)' functioning in
adults is the immunohematopoietic PSC. It continuously
replaces all renewable lymphoid cells and myeloid cells (1-3),
as well as a variety of other cell types including phagocytic
and mast cells (4). The PSC is characterized by maximum
self-renewal and maximum differentiating ability (1-3).
However, transplantation reduces marrow repopulating abil-
ities dramatically (5-7). Such transplantation effects have the-
oretical importance, not only for the hematology ofstem cells,
but also for one of the classic questions in biology: the max-
imal proliferative capacity of somatic cells. Studies by Carrel
(8) and Ebeling (9) convinced people for half a century that
such cells had potentially unlimited proliferative capacities.
However, modern studies of fibroblasts reversed that opinion
(10-12). It is still unknown whether the loss of PSC func-
tion with transplantation results from exhaustion of limited
proliferative capacity or whether untransplanted PSC may
proliferate without limit.
Transplantation effects also have clinical importance, be-
cause PSC are essential in successful marrow transplantation.
Furthermore, their huge differentiating and repopulating abil-
ities have the potential to make them important vehicles for
gene transplantation therapy, especially since they can be con-
veniently removed and transplanted in marrow cell suspensions.
There are two general mechanisms that may cause trans-
plantation damage: reductions in PSC concentrations, and
diminished repopulating ability per PSC. In the present re-
port we find damage from both of these mechanisms, since
transplanted marrow cells had a twofold reduction in PSC
concentration, but a seven- to eightfold reduction in re-
populating ability, compared with fresh marrow. We derive
our estimate of equivalent PSC concentration from the covar-
iance of joint measurements on lymphocytes and erythro-
cytes, a new technique that avoids a serious problem in vari-
ance calculations, the subtraction of an estimate of variance
resulting from experimental error (1, 2). Functional abilities
were estimated from competitive repopulation studies (5-7).
Materials and Methods
Mice. Different mouse strains may have genetic disparities
affecting histocompatibility and hybrid or allogeneic resistance. Since
these may influence PSC development, we used C57BL/6J (B6)
and congenic B6-Hbbd/Hbba, Gpi-1°/Gpi-1' (B6-Hbb' Gpi-1°) male
donors (1, 2) with B6 recipients. All were 2-4-mo-old male mice
in both experiments, except that donors ofpreviouslytransplanted
cells had been lethally irradiated and given 100 x 105 marrow cells
5-6 mo before the experiment, and therefore were 8-10 mo old.
Mice were produced and maintained at TheJackson Laboratory,
which is fully accredited by the American Association for the Ac-
creditation of Laboratory Animal Care. They were maintained in
isolated, environmentally controlled rooms with filtered air under
positive pressure, temperatures at 22°C, and lighting from 07:00
to 19:00 hours. Mice were fed a pelleted, pasteurized diet (96WA;
Emory Morse, Guilford, CT), and were not exposed to known
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antiviral titers when tested for 10 standard mouse viruses. Details
of theanimal husbandryarepublished in the Handbook on Genet-
ically Standardized Jax Mice, and quarterly updates are published
in the Animal Health and Genetic Quality Control Report (The
Jackson Laboratory, Bar Harbor, ME).
Marrow Transplantation.
￿
Recipients were lethally irradiated with
1,100rad in a
137C5gammairradiator (Shepherd Mark I;J.L. Shep-
herd & Associates, Glendale, CA) at a dose rate of 220 rad/min
15-18 hbefore themarrow was transplanted. Marrow cell suspen-
sionswere prepared from femurs and tibias ofeach donor.Thebones
were cleaned, the ends were opened, and the marrow was washed
outby repeated flushing with IMDM through a 23-gauge needle.
Clumps were dissociated by gently forcing them through a 1.00-
ml syringe against the bottom ofatest tube.Marrow suspensions
were filtered with 100-mesh nylon cloth, and marrow cells were
stored on ice. Nucleated cells were counted using a Coultermodel
ZBI Electronic Cell Counter (Coulter Electronics, Inc., Hialeah,
FL), after erythrocytes were lysedusingstandard lysing agents for
white cell counting. Cellswere injected intravenously through26-
gauge needles into the lateral tail veins of warmed recipients. In
each of theexperiments, lethally irradiated B6 recipients were given
the marrow doses detailed in the table footnotes in 0.50 ml, and
allrecipients of agiven dose were intravenously injected with equal
portions from the same mixture. Marrow cells of each type were
taken from a single donor cell pool in each experiment.
Recipient Cell Recovery.
￿
We estimated the contribution to the
total amounts of B6-type cells due to recovery of recipient cells
in groups of sevenlethally irradiated B6 recipients in each experi-
ment that were given 10 or 20 x 105 previously transplanted B6-
Hbbd Gpi-14 competitor cells alone. Averaging the means for tests
at each time point, and pooling Hb and GPI results, since they
were similar, percentages of host (B6) cells were very low, 4.1 ±
2.4(7) or 2.1 ± 1.9(7), givenas mean ± SD (number ofindividual
tests). Percentages of host cells mayhave had a slight tendency to
decline with time, as shown in Table 6. Thus, host recovery did
not contribute significant numbers of differentiated cells, even in
recipients of the lowest number of previously transplanted cells.
Percentages ofB6-type Lymphocytes (P) andErythrocytes (Pe). Lym-
phocytes from the blood were separated by density gradient cen-
trifugation as detailed previously (2), and the percentages of B6
type glucosephosphate isomerase (Gpi) were determined by den-
sitometry after electrophoresis. DonorB6 mice have the Gpi-16 al-
lele at the Gpi-1 locus; in electrophoresis this type forms a more
rapidlymigratingband from positive to negative than does theGpi-
1- allele. Erythrocytes were taken from the same blood samples and
percentages ofB6 type hemoglobin (Hb) were determined by den-
sitometry after electrophoresis. B6 mice have Hbb, (s, single) he-
moglobin, which formsan electrophoreticband migratingfarthest
from negative to positive on thestandard celluloseacetategels used,
while Hbbd (d, diffuse) hemoglobin has the Hbb-bld and Hbb-b2d
bands that are intermediate and slowest migrating, respectively.
Details oftheGpiand hemoglobin electrophoretic techniques have
been published previously (2). Blood was sampled at intervals of
>100 d, and each blood sample was tested for both lymphocyte
and erythrocyte percentages ofB6 type. Results aregiven as sample
means estimating Pi and Pe.
Estimation of PSC Numbers and Concentrations.
￿
For each in-
dividual in a group numbering n recipients getting identical ali-
quots from the same marrow cell pool, we measuretheB6 percen-
tages forlymphocytes andfor erythrocytes, Pi and Pe, at the same
sampling time after transplantation. We calculate: Mean = the
average of all 2n percentages which is the average of the 2 sample
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means estimating Pi and Pe, the percentages of B6 type lympho-
cytes anderythrocytes; SDL, SDE = the standard deviations of the
twosets of n measurements; r = lymphocyte/erythrocyte Pearson
correlation coefficient (L/E r); high correlations, suggest that the
sampledlymphocytes and erythrocytes aredescended from the same
precursors. Then covariance = r x SDL x SDE.
EstimatesofPSC number andconcentrationarecalculated from
thebinomial formula as in Eqs. 1and2below. Ifin each individual
there were just N such PSC that contributed equal fractions l/N
oflymphocytes and of erythrocytes, then equivalent PSC number
would be an estimate of N and equivalent PSC concentration an
estimate of the concentration of such PSC.
Equivalent PSC number = [(mean)(100-mean)]/covariance
(Eq. 1)
Equivalent PSC concentration = equivalent PSC number/num-
ber of injected cells
(Eq. 2)
The reciprocal of equivalent PSC number is an estimate of the
parameter introduced by Stone (13) and labeled irc. If the genetic
marking(B6 or not) does not affect clonal development, as should
be the case using congenic lines, rc is the probability that a ran-
domly picked lymphocyte and arandomly picked erythrocyte are
descendedfrom the same transplanted PSC. Equivalent PSCnumber
and concentration clearly have useful interpretations in terms of
the fundamental probability parameter 7rc, even when the assump-
tion that each PSC contributes equally is unrealistic. They should
then be regarded as experimentally ascertainable, inverse measures
of the common PSCclonality of the lymphocyte anderythrocyte
compartments. Furthermore, ifeach precursordoes notcontribute
equally, estimates of the equivalent PSC number and concentra-
tion reflect thoseprecursors contributing themost, and these are
especially interesting.
Estimation of Numbers and Concentrations for Continuously Func-
tioning Precursors. The methods described in the preceding para-
graphs are also applicable if the two measurements areB6 percen-
tages of either lymphocytes or erythrocytes at different sampling
times. As long as thesetimes arefarenough apartso that circulating
cellshave been renewedduring that interval, estimations ofcommon
continuously functioning precursors will still be labelled as PSC.
In these cases, ris the correlation coefficient relating the measures
on the same recipients at the two times; SD1 and SD2, the stan-
dard deviations of measurements at those times, are substituted
forSD, and SDE. High correlations suggest that thedifferentiated





In each of two experiments, percent-
ages of B6 type lymphocytes and erythrocytes, Pi and Pe,
were measured repeatedly at intervals of -100 d to follow
long-term changes in these populations. The basic feature
of the simple binomial neutral-marker model (1-3, 14-18) as-
sociating increasing variance with decreasing PSC numbers
was supported. Using previously transplanted cells, standard
deviations were highest in recipients of 20 x 105 cells,
reducing to about one-third of their value as the dose was
increased to 200 x 105 cells. Standard deviations were about
the same in recipients of 8 x 105 fresh marrow cells as in
recipients of 20 x 105 previously transplanted cells, sug-
gesting that PSC concentrations arehigher in fresh marrow.
PSC concentrations were estimatedin two ways: as common
How Transplantation Alters Primitive Immunohematopoietic Stem CellMarrow doses totaled 8 x 105 (8-F), half fresh B6 cells, and half fresh B6-Hbbd Gpi-la cells, or 20, 40, 80, and 200 x 105 cells, half from
carriers transplanted with B6 cells, and half from carriers transplanted with B6-Hbbd Gpi-1a marrow. All but the first dose (given as cell num-
ber "-F" for fresh marrow of each type) came from lethally irradiated B6 carriers given 100 x 105 marrow cells 5-6 mo previously.
Recipients were bled and tested 107, 243, 362, and 463 d after they were given the marrow cell mixtures. P1 and P, are the percentages of
B6-type lymphocytes and erythrocytes, respectively, and SDL,SDE are their sample standard deviations. The r values (L/E r) are Pearson's
product moment correlation coefficients of Pi and P.. The equivalent PSC number was calculated as P(100 - P)/covariance, where P is overall
mean percent B6 type, and covariance = r x (SDL x SDE). "Concentration" is the equivalent PSC concentration = equivalent PSC num-
ber/number of injected cells, and n is the number of recipients for which both Pi and P, were measured. Estimations of concentrations become
more meaningful as r approaches 1 .00 and the SDs approach the same value.
precursors of lymphocytes and erythrocytes in one blood
sample, or as precursors producing differentiated cellsduring
two samplings 101-145 d apart.
Common Precursors ofLymphocytes and Erythrocytes.
￿
Lym-
phoid/erythroid correlation coefficients (L/E r) in the same
recipients were very high in most groups. For example, at
243 d in Table 1, L/E r = 0.94 for groups receiving 8 x
105 fresh cells (8-F); and 0.77, 0.80, 0.88, and 0.85, for
groups receiving 20, 40, 80, and 200 x 105 previously trans-
planted marrow cells, respectively. These high r values sug-
gest that most differentiated lymphoid and erythroid cells
were descended from a small number of transplanted
precursors, as expected of true PSC. Equivalent PSC concen-
trations were NJ/105 for fresh marrow, and less than half




above, concentrations per 105 marrow cells were 1.1 for
groups receiving 8 x 105 fresh cells; and 0.5, 0.4, 0.3, and
0.6, for groups receiving 20, 40, 80, and 200 x 105 previ-
ously transplanted marrow cells, respectively. Equivalent PSC
numbers for retransplanted cells increase roughly proportion-
ally with the number of marrow cellsinjected, so that taking
Tables 1 and 2 together, there is no evidence of any system-
atic dependence of equivalent PSC concentration on dose.
Precursors of Differentiated Cells Over Hundreds of Days.
Correlation coefficients between Pt (or Pe) in the same recip-
ients at different times were also very high in most groups
afterthe first time point (Tables 3 and 4). Thus between times
2 and 3 (243-362 d) in Exp. 1, lymphoid cell correlation
coefficients (L2/L3 r) were 0.91 for groups receiving 8 x
105 fresh cells; and 0.78, 0.94, 0.80, and 0.73 for groups












107 Means P,,Pe 49,45 59,52 49,45 55,53 56,51
SDL,SDE 12,16 16,15 7,8 6,8 5,5
L/E r 0.73 0.93 0.82 0.64 0.33
n 16 15 16 16 16
Concentration 2.1 0.6 1 .3 1.0 1 .6
243 Means PiA 54,47 57,63 54,54 59,61 60,60
SDL,SDE 14,21 16,19 12,17 9,14 5,5
L/E r 0.94 0.77 0.80 0.88 0.85
n 16 15 16 15 16
Concentration 1 .1 0.5 0.4 0.3 0.6
362 Means P,A 59,50 60,66 59,60 60,66 64,64
SDL,SDE 19,23 20,18 16,20 14,14 8,8
L/E r 0.83 0.68 0.91 0.84 0.79
n 16 14 14 14 15
Concentration 0.8 0.5 0.2 0.2 0.2
463 Means P0, 60,50 54,66 61,73 67,67 63,67
SDL,SDE 21,23 29,21 19,23 11,15 9,7
L/E r 0.85 0.72 0.81 0.65 0.74
n 9 9 11 9 10
Concentration 0.8 0.3 0.2 0.3 0.2Footnotes are the same as in Table 1, except that this is an independent Exp. 2, and recipients were tested 152, 297, and 398 d after they
were given marrow mixtures.
Footnotes are the same as in Table 1, except that instead of P, and P,, calculations are based on P, and P, (or Pe and P,) for sampling times
1-2, 2-3, and 3-4.
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Table 3. Frequency of Continuously Functioning Precursor Cells (Exp. 1)
Total number of marrow cells injected (x 105)
Sampling Calculated
times statistics 8-F 20 40 80 200
d Lymphoid cells
107-243 L1/L2 r 0.61 0.70 0.78 0.66 0.49
Concentration 2.9 0.6 1.0 0.9 1.1
243-362 L2/L3 r 0.91 0.78 0.94 0.80 0.73
Concentration 1.3 0.5 0.4 0.4 0.4
362-463 L3/L4 r 0.97 0.97 0.92 0.70 0.59
Concentration 0.8 0.2 0.2 0.3 0.2
Erythroid cells
107-243 El/E2 r 0.86 0.93 0.75 0.86 0.62
Concentration 1.0 0.5 0.6 0.3 0.7
243-362 E2/E3 r 0.91 0.93 0.94 0.94 0.94
Concentration 0.7 0.4 0.2 0.2 0.3
362-463 E3/E4 r 0.93 0.98 0.97 0.98 0.88
Concentration 0.6 0.3 0.1 0.1 0.2












152 Means P,,P, 53,53 59,59 59,58 64,63 66,62
SDL,SDE 18,26 16,25 10,12 6,7 5,6
L/E r 0.92 0.96 0.95 0.70 0.69
n 13 13 15 16 16
Concentration 0.7 0.3 0.6 0.9 0.5
297 Means P,,P, 58,57 62,64 65,62 68,67 67,68
SDL,SDE 19,26 22,27 14,15 6,7 8,9
L/E r 0.76 0.91 0.92 0.50 0.90
n 13 12 15 16 16
Concentration 0.8 0.2 0.3 1.4 0.2
398 Means P,,P, 53,68 59,58 66,58 75,67 73,66
SDL,SDE 33,31 32,30 16,19 5,8 7,9
L/E r 0.73 0.98 0.91 0.11 0.21
n 8 9 11 13 12
Concentration 0.4 0.1 0.2 6.4 0.8Footnotes are the same as in Table 3.
receiving 20, 40, 80, and 200 x 105 previously transplanted
marrow cells, respectively (Table 3). These high correlations
suggest that most differentiated cells were descended from
the same precursors over hundreds of days, as expected ifPSC
and theirdescendants function continuously. As above, equiva-
lent PSC concentrations were -1/105 for fresh marrow, and
about one-thirdthat for transplanted marrow. In the example
mentioned above, equivalent PSC concentrations per 105
marrow cells were 1.3 for groups receiving 8 x 105 fresh




80, and 200 x 105 previously transplanted marrow cells,
respectively. Just as for the previous tables, Tables 3 and 4
together show that the equivalent PSC concentration for
retransplanted cells is roughly the same at all dose levels.
Equivalent PSC concentrations are summarized in Table
5 as "concentration from L,E" (Tables 1 and 2), "concentra-
tion over time L" (Tables 3 and 4, top half) and "concentra-
tion over time E" (Tables 3 and 4, bottom half). Equivalent
PSC concentrations tend to decline with time proportion-
ally in fresh and in previously transplanted cells; ratios of
In this summary of results in Tables 1-4, values for fresh marrow were taken from the group receiving 8 x 105 fresh marrow cells, while
medians of values for previously transplanted marrow (Retrans) were taken from groups receiving 20, 40, 80, and 200 x 105 retransplanted
marrow cells. "Concentrations from L, E" are summarized from Table 1 and 2. "Concentrations over time L or E" are summarized from Ta-
bles 3 and 4. The median of the concentration values for any two sampling times is listed at the later time. Fresh and retrans concentration
values were campared by the Wilcoxon signed-rank test; for Exp. 1 (n - 10), Z -
￿
-2.8 with P - 0.0049 and for Exp. 2 (n - 7), Z =
-2.0 with P = 0.041. Ratios calculated as concentration Retrans/concentration Fresh have means of 0.36 for Exp. 1 and 0.71 for Exp. 2,
with medians 0.32 and 0.70, respectively.
Table 5. Summaries of PSC Concentration Estimates
Concentrations from L, E Concentrations over time L Concentrations over time E
Exp. Days Fresh Retrans Ratio Fresh Retrans Ratio Fresh Retrans Ratio
1 107 2.1 1.15 0.55
1 243 1.1 0.45 0.41 2.9 0.95 0.33 1.0 0.55 0.55
1 362 0.8 0.2 0.25 1.3 0.4 0.31 0.7 0.25 0.36
1 463 0.8 0.25 0.31 0.8 0.2 0.25 0.6 0.15 0.25
2 152 0.7 0.55 0.79
2 297 0.8 0.25 0.31 1.2 0.45 0.38 0.5 0.35 0.7
2 398 0.4 0.5 1.25 0.5 0.45 0.9 0.4 0.25 0.63
Table 4. Frequency of Continuously Functioning Precursor Cells (Exp. 2)
Total number of marrow cells injected (x 105)
Sampling Calculated -
times statistics 8-F 20 40 80 200
d Lymphoid cells
152-297 L1/L2 r 0.79 0.98 0.92 0.48 0.73
Concentration 1.2 0.3 0.5 1.7 0.4
297-398 L2/L3 r 0.91 0.98 0.90 0.58 0.33
Concentration 0.5 0.2 0.3 1.7 0.6
Erythroid cells
152-297 E1/E2 r 0.88 0.96 0.94 0.65 0.73
Concentration 0.5 0.2 0.4 0.8 0.3
297-398 E2/E3 r 0.81 0.98 0.87 0.82 0.87
Concentration 0.4 0.2 0.3 0.6 0.2equivalent PSC concentrations in retransplanted marrow/fresh
marrow did not change consistently with time. They aver-
aged 0.36 in Exp. 1, and 0.71 in Exp. 2.
Effects of Transplantation on Functional Abilities.
￿
Relative
repopulating abilities of fresh and retransplanted cells may
be estimated from the percentages of B6 type in the following
experiment (Table 6): 10 x 105 fresh (10-F), or 33, 100, or
300 x 105 previously transplanted B6 cells, were each mixed
with 10 x 105 cell portions of fresh competitor cells. In
parentheses are calculated relative repopulating abilities ofB6
compared with competitor cells, where 100% means equal
repopulating abilities. With the same doses offresh B6 marrow
these averaged 91% in Exp. 1 and 139% in Exp. 2. However,
transplanted cells had average relative repopulating abilities
of 11.7% in Exp. 1 and 19.6% in Exp. 2 (Table 6). Adjusted
to a cell for cell basis, fresh marrow repopulated eight times
as well as previously transplanted marrow in Exp. 1, and seven
times as well in Exp. 2.
Discussion
Understanding how transplantation alters PSC, precursor
cells with the most repopulating ability over the longest period
of time, is important for three reasons: (a) These cells are
of basic interest as they have many properties of undifferen-
tiated embryonal cells but are found in adults; (b) they are
vital for long-term success in marrow transplantation, a treat-
ment of increasing clinical importance; and (c) they will be
vital in gene therapy in adults, when the genetically altered
cells will have to successfully repopulate over long time periods
in competition with the host's untreated cells.
The competitive repopulation techniques used in this study
directly assay the most important properties of PSC, their
long-term repopulating and differentiating functions over
hundreds of days. Estimates of PSC concentrations are not
exact because each precursor may not contribute equally to
the differentiated cell populations. However our estimates of
equivalent PSC concentrations represent the most interesting
cells, the precursors from which most of the differentiated
cells are descended. In addition they have a precise interpre-
tation in terms of the probability parameter wc (13, 18). It
is limited numbers of these precursors that cause most ofthe
covariance in Eq. 1. Numbers of precursors contributing less
to the differentiated cell populations will have little effect on
the covariance and will be underestimated (13).
The drop in estimated equivalent PSC concentrations after
107 d in Exp. 1 probably occurred because exhaustible
precursors, less primitive than true PSC, were present in the
original marrow grafts, but gradually were exhausted after
107 d (1, 2, 19). Since each PSC probably contributed much
more to the differentiated populations than did any of the
differentiated precursors, the observed covariances mostly
reflect limited PSC numbers, not numbers of more differen-
tiated cells.
An advantage in using covariance-based rather than variance-
based estimates is that bias arising from random experi-




Repopulating Abilities of Retransplanted Cells
The same cell pools used in Exps. 1 and 2 were used, with the
following recipient groups: 10 x 105 fresh B6 cells (results under
10-F), 33, 100, or 300 x 105 previously transplanted B6 cells
(results given under 33, 100, and 200) were mixed with 10 x 105
fresh B6-Hbbd Gpi-11 competitor cells, and given to groups of three
to four lethally irradiated B6 recipients. Host cell recovery was
tested in groups of seven lethally irradiated B6 recipients that were
given 10 or 20 x 105 previously transplanted B6-Hbbd Gpi-la compe-
titor cells alone (results given under 10-C and 20-C). Percentages of
B6 type hemoglobin and GPI were measured with those given in
Tables 1-4. Both Hb and GPI data gave similar results so their aver-
age values are given here. In the columns where B6 type cells-were
mixed with competitors, relative repopulating percentages of the B6
cells, given in parentheses, were calculated as follows: M = the
number of B6 cells (x 105) that would be needed to produce the
observed percent B6 (called "P") assuming both types had the same
repopulating ability, as is likely with congenic cells. The competitor
cells were given at a dosage of 10 x 105, so P = 100 x [M/(10
+ MI. By simple algebra, M = IOP/(100-P). Relative repopulating
percentages are then 100M/(actual number B6 cells). These averaged
11.7% for retransplanted and 91% for fresh cells in Exp. 1 ; they
were 19.6% for retransplanted and 139% for fresh cells in Exp. 2.
Thus the transplanted cells repopulated 12.9% ("l/8) and 14.1%
(ti1/7) as well as fresh, in the two experiments.
related in the two compartments is not present. Had variances
been used in the binomial formula as is usual (3, 13-17), esti-
mates of measurement error would have been needed for com-
parison with experimental standard deviations. Such estimates
are usually obtained from repeatedly measuring a standard
sample and do not include all random experimental error,
for example that due to effects of irradiation on individual
recipients, or that due to different conditions at different sam-
pling times when recipients are followed over time.
Transplantation reduced equivalent PSC concentrations
about twofold (Table 5). However, this reduction was not
sufficient to explain the seven- to eightfold reductions in
repopulating ability caused by transplantation in the same
experiments (Table 6). Thus, transplantation reduces the func-
tional ability per PSC as well as reducing PSC numbers.
There are two potential causes of transplantation damage:
(a) There may be excessive stimuli for PSC to differentiate
in the lethally irradiated recipients relative to the stimuli for







in groups receiving the
cell numbers (x 105):
100 300 10-C 20-C
1 107 46 (85) 40 (20) 55 (12) 73 (9) 3 3
1 243 48 (92) 29 (12) 54 (12) 72 (9) 7 3
1 362 49 (96) 32 (14) 49 (10) 73 (9) 4 0
1 463 - 25 (10) - - 3 1
2 152 55 (122) 52 (33) 61 (16) 76 (11) 8 3
2 297 61 (156) 46 (26) 60 (15) 82 (15) 2 5
2 398 - 45 (25) 61 (16) 85 (19) 2 0PSC to proliferate and maintain their numbers. This would
result in dilution of the slowly proliferating PSC by more
rapidly proliferating differentiated precursors, as suggested
byJones et al. (20). (b) Removal ofPSC from their microen-
vironments and transplantation into irradiatedrecipients may
cause damage.
We tested whether PSC were damaged due to irradiation
injury of the recipient stromal tissue by comparing transplanted
marrow from genetically anemic WIWI' recipients that were
repopulated without irradiation, and marrow from lethally








of transplantation into WI W° recipients were found, even
when marrow was transplanted by parabiosis to avoid han-
dling (21). Hybrid resistanceor graft-vs.-host effects may have
damaged the transplanted B6 marrow in the WBB6F1
W/W° recipients used, so the experiment should be repeated
using congenic recipients.
Transplantation damage should be preventable if it occurs
because transplanted PSC are suddenly exposed to high levels
of stimuli to differentiate, and these overbalance the stimuli
to replicate. Stimuli for PSC to differentiate may be reduced,
stimuli for them to replicate may be increased, or both.
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